About this document

RoActemra: Product Overview & Indications by juliyajoseph833 is a document available to read on EtoBox.

RoActemra is a tocilizumab concentrate for infusion indicated for treating severe rheumatoid arthritis, COVID-19, systemic juvenile idiopathic arthritis, and cytokine release syndrome. It is administered intravenously, with specific dosing guidelines based on patient weight and condition, and requires monitoring for laboratory abnormalities. Caution is advised due to the risk of serious infections and other contraindications.

Author

juliyajoseph833

Language

EN